Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Stupp

Showing results (131-140 of 314) with videos related to

Pageof 32
Sort By:
Neuro-Oncology|February 16, 2026
Imaging Biomarkers for Detecting IDH-mutations and Monitoring Response to Novel Targeted Therapies: Current Insights and Future PerspectivesArchith Rajan, Felipe Rosero Castro, Laiz Laura de Godoy, et al.
BMC Cancer|May 26, 2020
Experiences and views of different key stakeholders on the feasibility of treating cancer-related fatigueClaudia Canella, Michael Mikolasek, Matthias Rostock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2020
Determining the Optimal Adjuvant Therapy for Improving Survival in Elderly Patients with Glioblastoma: A Systematic Review and Network Meta-analysisFarshad Nassiri, Shervin Taslimi, Justin Z Wang, et al.
Cancer Treatment Reviews|September 20, 2005
Radiation recall: a well recognized but neglected phenomenonDavid Azria, Nicolas Magné, Abderrahim Zouhair, et al.
Neuro-Oncology Practice|March 20, 2025
Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: Does time of administration matter?Marjolein Geurts, Luzia Berchtold, Franz Koenig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanismsArnab Chakravarti, Michael G Erkkinen, Ulf Nestler, et al.
Neuro-Oncology Advances|August 11, 2022
Associations of levetiracetam use with the safety and tolerability profile of chemoradiotherapy for patients with newly diagnosed glioblastomaKatharina Seystahl, Felix Boakye Oppong, Emilie Le Rhun, et al.
Neuro-Oncology|March 21, 2022
Prognostic significance of therapy-induced myelosuppression in newly diagnosed glioblastomaEmilie Le Rhun, Felix Boakye Oppong, Maureen Vanlancker, et al.
Integrative Cancer Therapies|November 23, 2017
Developing an Integrative Treatment Program for Cancer-Related Fatigue Using Stakeholder Engagement - A Qualitative StudyClaudia Canella, Michael Mikolasek, Matthias Rostock, et al.
International Journal of Cancer|February 29, 2008
Tenascin-W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patientsMartin Degen, Florence Brellier, Susanne Schenk, et al.
Pageof 32

Showing results (131-140 of 314) with videos related to

Sort By:
Pageof 32
Neuro-Oncology|February 16, 2026
Imaging Biomarkers for Detecting IDH-mutations and Monitoring Response to Novel Targeted Therapies: Current Insights and Future PerspectivesArchith Rajan, Felipe Rosero Castro, Laiz Laura de Godoy, et al.
BMC Cancer|May 26, 2020
Experiences and views of different key stakeholders on the feasibility of treating cancer-related fatigueClaudia Canella, Michael Mikolasek, Matthias Rostock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2020
Determining the Optimal Adjuvant Therapy for Improving Survival in Elderly Patients with Glioblastoma: A Systematic Review and Network Meta-analysisFarshad Nassiri, Shervin Taslimi, Justin Z Wang, et al.
Cancer Treatment Reviews|September 20, 2005
Radiation recall: a well recognized but neglected phenomenonDavid Azria, Nicolas Magné, Abderrahim Zouhair, et al.
Neuro-Oncology Practice|March 20, 2025
Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: Does time of administration matter?Marjolein Geurts, Luzia Berchtold, Franz Koenig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanismsArnab Chakravarti, Michael G Erkkinen, Ulf Nestler, et al.
Neuro-Oncology Advances|August 11, 2022
Associations of levetiracetam use with the safety and tolerability profile of chemoradiotherapy for patients with newly diagnosed glioblastomaKatharina Seystahl, Felix Boakye Oppong, Emilie Le Rhun, et al.
Neuro-Oncology|March 21, 2022
Prognostic significance of therapy-induced myelosuppression in newly diagnosed glioblastomaEmilie Le Rhun, Felix Boakye Oppong, Maureen Vanlancker, et al.
Integrative Cancer Therapies|November 23, 2017
Developing an Integrative Treatment Program for Cancer-Related Fatigue Using Stakeholder Engagement - A Qualitative StudyClaudia Canella, Michael Mikolasek, Matthias Rostock, et al.
International Journal of Cancer|February 29, 2008
Tenascin-W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patientsMartin Degen, Florence Brellier, Susanne Schenk, et al.
Pageof 32